Balaji Amines Ltd
Balaji Amines Ltd specialises in manufacturing Methylamines, Ethylamines, Derivatives of specialty chemicals and Pharma Excipients. These have been the main products, it also have facilities for the manufacturing of derivatives, which are down-stream products for various pharma/pesticide industries apart from user specific requirements. It is one of the largest manufacturers of aliphatic amines in India. [1]
- Market Cap ₹ 7,478 Cr.
- Current Price ₹ 2,308
- High / Low ₹ 3,844 / 2,250
- Stock P/E 18.0
- Book Value ₹ 446
- Dividend Yield 0.26 %
- ROCE 50.2 %
- ROE 34.4 %
- Face Value ₹ 2.00
Pros
- Company is almost debt free.
- Company is expected to give good quarter
- Company has delivered good profit growth of 35.5% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 28.5%
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
347 | 447 | 509 | 608 | 616 | 640 | 668 | 858 | 940 | 935 | 1,308 | 2,319 | 2,642 | |
284 | 367 | 429 | 517 | 515 | 514 | 519 | 676 | 747 | 754 | 935 | 1,689 | 1,901 | |
Operating Profit | 63 | 81 | 80 | 91 | 102 | 127 | 149 | 182 | 193 | 181 | 373 | 630 | 741 |
OPM % | 18% | 18% | 16% | 15% | 17% | 20% | 22% | 21% | 21% | 19% | 29% | 27% | 28% |
2 | 4 | 4 | 3 | 4 | 3 | 9 | 12 | 4 | 5 | 6 | 7 | 13 | |
Interest | 14 | 21 | 25 | 32 | 35 | 22 | 13 | 9 | 13 | 23 | 18 | 17 | 16 |
Depreciation | 8 | 10 | 13 | 16 | 20 | 19 | 20 | 19 | 20 | 32 | 34 | 42 | 43 |
Profit before tax | 43 | 53 | 46 | 46 | 51 | 88 | 126 | 166 | 165 | 131 | 327 | 578 | 695 |
Tax % | 38% | 32% | 32% | 27% | 35% | 34% | 34% | 32% | 29% | 26% | 25% | 28% | |
Net Profit | 27 | 36 | 31 | 34 | 33 | 58 | 82 | 113 | 117 | 97 | 243 | 418 | 499 |
EPS in Rs | 8.21 | 11.00 | 9.62 | 10.34 | 10.25 | 17.78 | 25.42 | 34.93 | 36.27 | 32.34 | 73.51 | 113.71 | 127.71 |
Dividend Payout % | 7% | 7% | 14% | 10% | 12% | 11% | 9% | 7% | 8% | 10% | 5% | 5% |
Compounded Sales Growth | |
---|---|
10 Years: | 18% |
5 Years: | 28% |
3 Years: | 35% |
TTM: | 48% |
Compounded Profit Growth | |
---|---|
10 Years: | 27% |
5 Years: | 36% |
3 Years: | 47% |
TTM: | 26% |
Stock Price CAGR | |
---|---|
10 Years: | 48% |
5 Years: | 30% |
3 Years: | 80% |
1 Year: | -31% |
Return on Equity | |
---|---|
10 Years: | 26% |
5 Years: | 27% |
3 Years: | 29% |
Last Year: | 34% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Sep 2022 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | |
Reserves | 106 | 139 | 165 | 195 | 221 | 274 | 356 | 461 | 568 | 652 | 888 | 1,243 | 1,438 |
165 | 216 | 209 | 262 | 256 | 173 | 105 | 152 | 227 | 260 | 127 | 101 | 111 | |
88 | 105 | 139 | 158 | 139 | 152 | 168 | 229 | 244 | 195 | 289 | 524 | 500 | |
Total Liabilities | 365 | 466 | 519 | 620 | 623 | 605 | 635 | 848 | 1,046 | 1,113 | 1,310 | 1,875 | 2,056 |
160 | 196 | 234 | 325 | 341 | 341 | 325 | 316 | 320 | 573 | 543 | 681 | 784 | |
CWIP | 12 | 25 | 63 | 8 | 3 | 16 | 25 | 123 | 269 | 46 | 173 | 141 | 35 |
Investments | 8 | 8 | 20 | 20 | 0 | 0 | 0 | 0 | 0 | 48 | 0 | 0 | 25 |
186 | 237 | 202 | 267 | 278 | 248 | 284 | 409 | 457 | 446 | 594 | 1,053 | 1,211 | |
Total Assets | 365 | 466 | 519 | 620 | 623 | 605 | 635 | 848 | 1,046 | 1,113 | 1,310 | 1,875 | 2,056 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
14 | 53 | 94 | 111 | 56 | 85 | 60 | 140 | 94 | 144 | 110 | 232 | |
-59 | -56 | -86 | -50 | -4 | -29 | -10 | -135 | -119 | -130 | -62 | -134 | |
51 | -1 | -10 | -53 | -55 | -54 | -55 | 16 | 21 | -26 | -37 | -66 | |
Net Cash Flow | 5 | -5 | -2 | 7 | -3 | 2 | -5 | 21 | -4 | -12 | 11 | 32 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 78 | 67 | 74 | 79 | 71 | 71 | 68 | 73 | 65 | 81 | 85 | 93 |
Inventory Days | 134 | 149 | 66 | 87 | 114 | 80 | 106 | 70 | 116 | 77 | 64 | 66 |
Days Payable | 64 | 48 | 42 | 83 | 48 | 58 | 55 | 56 | 60 | 42 | 44 | 53 |
Cash Conversion Cycle | 148 | 168 | 99 | 83 | 136 | 93 | 119 | 87 | 120 | 116 | 104 | 106 |
Working Capital Days | 111 | 121 | 75 | 67 | 95 | 70 | 78 | 74 | 89 | 102 | 91 | 93 |
ROCE % | 24% | 23% | 19% | 18% | 18% | 24% | 30% | 32% | 25% | 18% | 35% | 50% |
Documents
Announcements
- Board Meeting Intimation for Considering And Approving The Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended 31St December, 2022. 2d
- Announcement under Regulation 30 (LODR)-Credit Rating 12 Jan
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
6 Jan - Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st December, 2022
- Closure of Trading Window 31 Dec 2022
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 29 Dec 2022
Annual reports
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2011
from nse
-
Financial Year 2010
from bse
-
Financial Year 2010
from nse
Concalls
-
Oct 2022TranscriptPPT
-
Aug 2022TranscriptPPT
-
May 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
-
Jun 2021Transcript PPT
-
Feb 2021Transcript PPT
-
Nov 2020Transcript PPT
-
Aug 2020Transcript PPT
-
Jul 2020Transcript PPT
-
Feb 2020Transcript PPT
-
Jan 2020TranscriptPPT
-
Dec 2019Transcript PPT
-
Nov 2019TranscriptPPT
-
Aug 2019Transcript PPT
-
Jul 2019Transcript PPT
-
Aug 2018TranscriptPPT
-
May 2018TranscriptPPT
-
Feb 2018TranscriptPPT
-
Feb 2017TranscriptPPT
-
Feb 2017TranscriptPPT
Product Portfolio[1]
The company has a diversified product portfolio with a basket of over 25 different products. These products are categorised under 3 main categories i.e. Amines, Amine derivatives and Specialty & Other chemicals. Its products includes Methyl Amines, Ethyl amines, Amino Ethanol, acetamide, amine hydrochloride, methyl urea, choline chloride, morpholine, etc.
Its products find application in many industries like Pharma, Agro, Rubber chemicals, photographic chemicals, rocket fuel, pesticides, solvents, performance chemicals, water treatment chemicals, etc.